Skip to main content
Sandeep Juneja

Sandeep Juneja

Forum Advisory Group member since 2016
Geneva, Switzerland
Senior Vice President of Market Access, TB Alliance

Sandeep leads the TB Alliance’s work on the design and implementation of market interventions and access strategies for rapid adoption and uptake of new TB regimens globally. Previously, Sandeep led Business Development at the Medicines Patent Pool, Geneva, where he forged alliances with the pharmaceutical industry, research institutes and other public health stakeholders to increase access to TB, HIV and HCV medicines. He spent 17 years in the pharmaceutical industry in diverse roles, including P&L leadership at country and regional levels, M&A and investor relations. He was responsible for building an HIV and malaria franchise in low- and middle-income countries that opened access to HIV medicines in more than 60 countries and the development of an NCE for Malaria.

Sandeep is passionate about shortening the gap between R&D and market availability of novel medicines, especially in low- and middle-income countries. He has served on several committees and panels related to access to medicines, such as the Advisory Board of the Medicines4All Institute, Steering Committee on Universal Access, Global Fund Procurement Advisory Panel, and Global Fund Market Dynamics Advisory Group.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.